Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Home
News
Press Releases

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

February 2024

02.29.2024
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
- Financial
- Investments

December 2023

12.14.2023
Pfizer Completes Acquisition of Seagen
- Corporate
- Investments
12.12.2023
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen

March 2023

03.13.2023
Pfizer Invests $43 Billion to Battle Cancer
- Financial
- Investments

October 2022

10.05.2022
Pfizer Completes Acquisition of Global Blood Therapeutics
- Financial
- Investments
10.03.2022
Pfizer Completes Acquisition of Biohaven Pharmaceuticals

August 2022

08.08.2022
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
- Financial
- Investments

June 2022

06.28.2022
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
- Financial
- Investments
06.23.2022
Valneva and Pfizer Announce Closing of Equity Investment
06.09.2022
Pfizer Completes Acquisition of ReViral
- Financial
- Investments
06.06.2022
Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
06.01.2022
Pfizer Provides Update on Ownership Interest in Haleon
- Investments

Current page 1
Page 2
Page 3

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube